Understanding Alistipes finegoldii in Your Gut Microbiome

Alistipes finegoldii: a specialized member of the Bacteroidetes

Alistipes finegoldii is a bacterial species found in the human gut, among other settings. It grows without oxygen and belongs to the group traditionally called Bacteroidetes, now also known as Bacteroidota. A stool profile can detect its DNA and estimate its share of the assigned sequences. Initially, that is a description of the sample.

The species has an interesting metabolism. In the laboratory culture described in the literature, it produced mainly succinate, with smaller amounts of acetate and propionate. It can also form indole from tryptophan. These characteristics help researchers explore its possible interactions in the gut. Detecting it in your sample does not reveal which compounds are being produced there or in what amounts. Review including the species description

What this species reveals about the gut ecosystem

Research interest extends beyond digestion. A 2025 paper found an association between A. finegoldii and better responses to cancer immunotherapy across several patient cohorts. Cell and animal experiments suggested a mechanism: a bacterial lipoprotein affected signals that draw particular immune cells into tumor tissue. This is an intriguing direction for treatment research, but the paper does not establish self-treatment with a bacterial supplement. Study

There are also early findings on gut-brain communication. In mouse models of chronic pain, live A. finegoldii supplementation and investigations involving hippuric acid improved several pain and behavioral measures. Whether this can lead to effective treatment in people remains a separate research question. 2026 animal experiment

These findings show why the species is interesting. They do not mean that a higher stool abundance is always better. Earlier literature on the Alistipes genus describes different associations depending on the species, condition and experimental model. Review

Putting your A. finegoldii result in context

A percentage usually describes relative abundance. Its share can rise because other microbes become less common, even if A. finegoldii itself has not increased. A comparison with a laboratory reference group is not a universal health target either.

There is no established personal ideal range for A. finegoldii from which treatment can be prescribed. Even a result combined with high diversity or other bacterial names does not, by itself, demonstrate an intact gut barrier, good nutrient absorption or low inflammation. The international consensus on microbiome testing therefore distinguishes describing a community from drawing clinically useful conclusions. Consensus

If you have symptoms, their pattern and accompanying features are a better starting point. Additional investigations should answer a specific medical question, rather than simply explain an unusual bacterial result.

Limits to interpretation

How accurately a species is identified depends on the method, sequencing depth and reference database. A 16S analysis often cannot distinguish closely related species reliably. Shotgun sequencing offers more information, but does not guarantee error-free identification. The methods comparison cited in the original article used chicken samples; it does not validate a commercial human test. Methods study

Collection, storage, medicines and stool consistency also affect interpretation. A stool sample does not represent every niche along the intestinal lining. Results from different providers are therefore not automatically comparable. Consensus

A. finegoldii as a clue to change

In research, repeated measurements can help connect community changes with diet, disease or treatment. In everyday care, however, the question needs to be one whose answer actually improves a decision. Routine A. finegoldii monitoring after every dietary change is not an established standard of care.

You can follow your digestion without a target number: which foods do you tolerate, how do your bowel habits change, and which symptoms persist? These observations are often immediately useful in a medical appointment or nutrition consultation.

Frequently asked questions

What does an Alistipes finegoldii test measure?

Depending on the service, it detects DNA from the species or estimates its share of a broader microbiome profile. It does not automatically measure RNA, fungi, active metabolic pathways or the metabolites actually produced. Each would require different or additional methods.

How is the sample collected?

Use the designated stool kit and follow its instructions. Avoid contact with toilet water, label the container, and follow storage and shipping times. Do not independently change medicines or diet for the measurement. Consensus

What can the result tell me about my health?

It describes part of your microbial community. Research is investigating interesting connections with immunity and metabolism. The individual result cannot reliably establish how well you absorb nutrients or how inflamed your gut is.

How accurate and reliable are these tests?

That depends on the particular test. A technically accurate DNA measurement and a clinically useful result are different requirements. Ask about species-level resolution, the reference group and studies evaluating the test’s intended use. Consensus

How often should I test Alistipes finegoldii?

Annual screening or checks every three to six months are not established standards. It is worth discussing repeats when they address a specific medical or research question. An unusual comparison result alone does not justify a testing calendar.

Can Alistipes finegoldii populations change quickly?

Microbial communities change with diet, medicines and illness, among other factors. How much this particular species changes in one person, and when a pattern stabilizes, cannot be predicted universally in days or weeks. Its relative share can also shift while its absolute amount remains unchanged.

Are Alistipes finegoldii results diagnostic?

The abundance of this species is not a stand-alone diagnosis or a validated general measure of “imbalance” or resilience. Persistent symptoms should be investigated according to your medical history and what you are experiencing.

How can I support my microbiome after the test?

A high or low result does not point to a particular probiotic or prebiotic. A varied diet that you tolerate is a reasonable approach. If you are prone to bloating, introduce additional fiber gradually.

If digestive symptoms severely restrict your food choices, qualified nutrition advice can help. The goals are adequate nutrition and feeling better. New findings about A. finegoldii may open up further possibilities, but they do not currently replace an individually justified treatment plan.

Sources and original literature

• Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. (2020). The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Publication

• Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. (2016). From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Publication

• Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A. (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Publication

• Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O’Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Zeller G, Koren O, Tun H, Valles-Colomer M, Collado MC, Fischer M, Allegretti J, Iqbal T, Chassaing B, Keller J, Baunwall SM, Abreu M, Barbara G, Zhang F, Ponziani FR, Costello SP, Paramsothy S, Kao D, Kelly C, Kupcinskas J, Youngster I, Franceschi F, Khanna S, Vehreschild M, Link A, De Maio F, Pasolli E, Miguez AB, Brigidi P, Posteraro B, Scaldaferri F, Stojanovic MR, Megraud F, Malfertheiner P, Masucci L, Arumugam M, Kaakoush N, Segal E, Bajaj J, Leong R, Cryan J, Weersma RK, Knight R, Guarner F, Shanahan F, Cani PD, Elinav E, Sanguinetti M, de Vos WM, El-Omar E, Dorè J, Marchesi J, Tilg H, Sokol H, Segata N, Cammarota G, Gasbarrini A, Ianiro G. (2025). International consensus statement on microbiome testing in clinical practice. Publication

• Wu et al. (2025). Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors.

• Ding et al. (2026). Intermittent fasting alleviates neuropathic pain and cognitive deficits via an Alistipes finegoldii-Hippuric Acid-STING neuroimmune axis.

Origin and source context

Adapted for Nutrient Desk from the original article. The patient observations, cell experiments and animal studies described here provide different kinds of evidence. They do not yet establish a personal stool-abundance target for this species.